Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV single-arm study of Lucentra for upper facial wrinkles
IRCT20150303021315N39Phase 4Completed
- Sponsor
- Espad Pharmed
- Start
- Nov 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lucentra, sponsored by Espad Pharmed. Primary endpoints: Safety and Participant satisfaction. Started Nov 2025; status: completed.
02
Drugs
Lucentra
Beyond the preview
Go deeper on IRCT20150303021315N39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150303021315N39.